Literature DB >> 26385859

[Proton therapy of pediatric rhabdomyosarcoma: Same tumor control as photon therapy, with less adverse effects].

Kristin Gurtner1, Michael Baumann2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26385859     DOI： 10.1007/s00066-015-0878-3

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  7 in total

1.  Parameningeal rhabdomyosarcoma: outcomes and opportunities.

Authors:  Joanna C Yang; Leonard H Wexler; Paul A Meyers; Suzanne L Wolden
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-09-25       Impact factor: 7.038

2.  Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma--a report from the IRSG.

Authors:  S S Donaldson; J Meza; J C Breneman; W M Crist; F Laurie; S J Qualman; M Wharam
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-11-01       Impact factor: 7.038

3.  Late complications of therapy in 213 children with localized, nonorbital soft-tissue sarcoma of the head and neck: A descriptive report from the Intergroup Rhabdomyosarcoma Studies (IRS)-II and - III. IRS Group of the Children's Cancer Group and the Pediatric Oncology Group.

Authors:  R B Raney; L Asmar; R Vassilopoulou-Sellin; M J Klein; S S Donaldson; J Green; R Heyn; M Wharam; A S Glicksman; E A Gehan; J Anderson; H M Maurer
Journal:  Med Pediatr Oncol       Date:  1999-10

4.  Late effects of therapy in 94 patients with localized rhabdomyosarcoma of the orbit: Report from the Intergroup Rhabdomyosarcoma Study (IRS)-III, 1984-1991.

Authors:  R B Raney; J R Anderson; J Kollath; R Vassilopoulou-Sellin; M J Klein; R Heyn; A S Glicksman; M Wharam; W M Crist; H M Maurer
Journal:  Med Pediatr Oncol       Date:  2000-06

5.  Radiation therapy target volume reduction in pediatric rhabdomyosarcoma: implications for patterns of disease recurrence and overall survival.

Authors:  Bree R Eaton; Mark W McDonald; Sungjin Kim; Robert B Marcus; Anna L Sutter; Zhengjia Chen; Natia Esiashvili
Journal:  Cancer       Date:  2012-12-27       Impact factor: 6.860

6.  Incidence of second malignancies among patients treated with proton versus photon radiation.

Authors:  Christine S Chung; Torunn I Yock; Kerrie Nelson; Yang Xu; Nancy L Keating; Nancy J Tarbell
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-06-15       Impact factor: 7.038

7.  Local control after intensity-modulated radiotherapy for head-and-neck rhabdomyosarcoma.

Authors:  Amarinthia E Curtis; M Fatih Okcu; Murali Chintagumpala; Bin S Teh; Arnold C Paulino
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-05-22       Impact factor: 7.038
  7 in total
  1 in total

1.  Proton therapy of iris melanoma with 50 CGE : Influence of target volume on clinical outcome.

Authors:  Aline I Riechardt; Bettina Karle; Dino Cordini; Jens Heufelder; Volker Budach; Antonia M Joussen; Johannes Gollrad
Journal:  Strahlenther Onkol       Date:  2017-06-19       Impact factor: 3.621
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.